Coherent Introduces Osprey, a Compact Femtosecond Laser for Optogenetics, Microsurgery, and Medical Device Manufacturing
Coherent (NYSE:COHR) has introduced Osprey, a new femtosecond laser designed for optogenetics, microsurgery, and medical device manufacturing. The laser delivers pulse energies up to 5 µJ and sub-350 fs pulse widths with exceptional beam quality and pointing stability.
Key features include industrial-grade reliability, simplified integration, and high performance enabled by ultrafast fiber laser technology. The system operates on a standard 24V DC supply with power draw under 150W, featuring integrated AOM and wide dispersion pre-compensation for complex optical paths.
Qualification units are available now, with volume production starting January 2026. The product complements Coherent's existing ultrafast portfolio, including Monaco and Axon series.
Coherent (NYSE:COHR) ha presentato Osprey, un nuovo laser a femtosecondi progettato per optogenetica, microchirurgia e produzione di dispositivi medici. Il laser offre energie di impulso fino a 5 µJ e durate di impulso inferiori a 350 fs, garantendo un'eccellente qualità del fascio e stabilità del puntamento.
Le caratteristiche principali includono affidabilità industriale, integrazione semplificata e prestazioni elevate grazie alla tecnologia di laser a fibra ultrarapida. Il sistema funziona con un'alimentazione standard a 24V DC con un consumo inferiore a 150W, integrando AOM e una pre-compensazione della dispersione ampia per percorsi ottici complessi.
Unità di qualificazione sono già disponibili, con produzione in volume prevista per gennaio 2026. Il prodotto completa la gamma ultrarapida esistente di Coherent, che include le serie Monaco e Axon.
Coherent (NYSE:COHR) ha presentado Osprey, un nuevo láser de femtosegundos diseñado para optogenética, microcirugía y fabricación de dispositivos médicos. El láser ofrece energías de pulso de hasta 5 µJ y anchos de pulso inferiores a 350 fs, con una calidad de haz excepcional y estabilidad en el apuntado.
Las características clave incluyen fiabilidad industrial, integración simplificada y alto rendimiento gracias a la tecnología de láser de fibra ultrarrápida. El sistema funciona con una alimentación estándar de 24V DC con un consumo inferior a 150W, incorporando AOM y una precompensación de dispersión amplia para trayectorias ópticas complejas.
Las unidades de calificación están disponibles ahora, con producción en volumen a partir de enero de 2026. El producto complementa la cartera ultrarrápida existente de Coherent, que incluye las series Monaco y Axon.
Coherent (NYSE:COHR)는 광유전학, 미세수술 및 의료기기 제조를 위해 설계된 새로운 펨토초 레이저 Osprey를 출시했습니다. 이 레이저는 최대 5 µJ의 펄스 에너지와 350 펨토초 미만의 펄스 폭을 제공하며 뛰어난 빔 품질과 지향 안정성을 자랑합니다.
주요 특징으로는 산업용 등급의 신뢰성, 간소화된 통합, 초고속 광섬유 레이저 기술로 구현된 높은 성능이 포함됩니다. 이 시스템은 표준 24V DC 전원으로 작동하며 소비 전력은 150W 미만이고, 복잡한 광 경로를 위한 통합 AOM 및 광범위한 분산 사전 보상을 특징으로 합니다.
검증용 유닛은 현재 이용 가능하며, 대량 생산은 2026년 1월부터 시작됩니다. 이 제품은 Coherent의 기존 초고속 제품군인 Monaco 및 Axon 시리즈를 보완합니다.
Coherent (NYSE:COHR) a lancé Osprey, un nouveau laser femtoseconde conçu pour l’optogénétique, la microchirurgie et la fabrication de dispositifs médicaux. Ce laser délivre des énergies de pulsation allant jusqu’à 5 µJ et des durées d’impulsion inférieures à 350 fs avec une qualité de faisceau exceptionnelle et une grande stabilité de pointage.
Les principales caractéristiques comprennent une fiabilité de niveau industriel, une intégration simplifiée et des performances élevées grâce à la technologie laser à fibre ultrarapide. Le système fonctionne avec une alimentation standard 24V DC et une consommation inférieure à 150W, intégrant un AOM et une précompensation de dispersion large pour les trajets optiques complexes.
Des unités de qualification sont disponibles dès maintenant, avec une production en volume prévue pour janvier 2026. Ce produit complète la gamme ultrarapide existante de Coherent, incluant les séries Monaco et Axon.
Coherent (NYSE:COHR) hat Osprey vorgestellt, einen neuen Femtosekundenlaser, der für Optogenetik, Mikrochirurgie und die Herstellung medizinischer Geräte entwickelt wurde. Der Laser liefert Impulsenergien von bis zu 5 µJ und Impulsbreiten unter 350 fs bei außergewöhnlicher Strahlqualität und Stabilität der Ausrichtung.
Zu den Hauptmerkmalen gehören industrielle Zuverlässigkeit, vereinfachte Integration und hohe Leistung, ermöglicht durch ultrafast-Faserlasertechnologie. Das System arbeitet mit einer Standard-24V-Gleichstromversorgung bei einem Stromverbrauch von unter 150W und verfügt über integrierte AOM sowie eine breite Dispersionsvor-Kompensation für komplexe optische Wege.
Qualifikationseinheiten sind jetzt verfügbar, mit Serienproduktion ab Januar 2026. Das Produkt ergänzt das bestehende ultrafast-Portfolio von Coherent, einschließlich der Serien Monaco und Axon.
- Advanced fiber-based architecture delivers superior performance and stability
- Low power consumption under 150W with standard 24V DC supply compatibility
- Expands product portfolio for growing medical and life sciences markets
- Designed for industrial-grade reliability and simplified integration
- Volume production not starting until January 2026
- -
Insights
Coherent's new Osprey femtosecond laser offers significant technical advantages for medical applications, strengthening their position in high-margin specialty markets.
Coherent's introduction of the Osprey femtosecond laser represents a strategic expansion of their ultrafast laser portfolio specifically targeting high-value medical and life sciences applications. The technical specifications - 5 µJ pulse energies and sub-350 fs pulse widths - place this product in the premium segment of ultrafast lasers designed for precision applications.
What stands out is Osprey's fiber-based architecture, which addresses key customer pain points in clinical and industrial settings where reliability and integration simplicity are paramount. The power efficiency (drawing under 150W) and 24V DC compatibility significantly reduce operational costs and integration complexity compared to traditional solid-state ultrafast lasers that typically require specialized power supplies and cooling.
Coherent is smartly positioning this product at the intersection of several growth markets: optogenetics (neuroscience research), microsurgery (minimally invasive procedures), and medical device manufacturing (precision micromachining). These applications command premium pricing due to their mission-critical nature and regulatory requirements.
The technical features addressing stability and reliability indicate Coherent is targeting the transition of ultrafast laser technology from research laboratories to commercial and clinical settings - a significant market expansion opportunity. By completing their product portfolio alongside the Monaco and Axon series, Coherent is creating an ecosystem strategy that increases switching costs for customers once they adopt the Coherent platform.
SAXONBURG, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today introduces Osprey, its newest femtosecond laser designed for demanding applications in optogenetics, microsurgery, and medical device manufacturing. Engineered for precision and reliability, Osprey delivers pulse energies of up to 5 µJ and sub-350 fs pulse widths. Osprey delivers exceptional beam quality and pointing stability, all in a compact form factor and with industry-leading power efficiency. These features make it ideal for integration into precision microscopes and advanced medical tools.
The introduction of Osprey comes at a pivotal moment as femtosecond lasers move beyond research settings into clinical and industrial environments. In these applications, repeatability, reliability, beam quality, and cost efficiency have become more critical than peak power. Osprey addresses these evolving needs with industrial-grade reliability, simplified integration, and high performance enabled by the latest ultrafast fiber laser technology.
“Osprey combines decades of ultrafast laser expertise with a fiber-based architecture that delivers best-in-class performance and reliability,” said Dr. Chris Dorman, Executive Vice President, Lasers Business Group at Coherent. “We designed Osprey to deliver clean, stable, high-quality femtosecond pulses with minimal power draw and maximum system stability – a game-changer for medical and life sciences applications.”
Osprey’s fiber-based architecture delivers significant performance advantages over competing systems. Leveraging deep expertise in ultrafast fiber technology, the laser generates high-quality pulses using specifically designed solid-core fibers that are virtually free of aging effects while maintaining superior ruggedness and pointing stability. With a power draw under 150 W, Osprey runs on a standard 24 V DC supply. Integrated AOM and wide dispersion pre-compensation enable smooth operation across complex optical paths, critical for wide field-of-view imaging and fiber delivery systems.
Osprey complements the existing ultrafast portfolio from Coherent for two-photon optogenetics, which include the Monaco and the Axon series, optimized for two-photon calcium imaging. Together, this comprehensive lineup provides researchers and engineers with a complete toolkit for advanced bioimaging and microsurgery workflows.
Qualification units of Osprey are available, with volume production scheduled for January 2026. Coherent will showcase the Osprey at LASER World of Photonics Munich 2025.
About Coherent
Coherent empowers market innovators to define the future through breakthrough technologies, from materials to systems. We deliver innovations that resonate with our customers in diversified applications for the industrial, communications, electronics, and instrumentation markets. Coherent has research and development, manufacturing, sales, service, and distribution facilities worldwide. For more information, please visit us at coherent.com.
Media Contact:
innovations@coherent.com
FAQ
What are the key specifications of Coherent's new Osprey femtosecond laser?
When will Coherent (NYSE:COHR) begin volume production of the Osprey laser?
What applications is the Coherent Osprey laser designed for?
How does the Osprey laser complement Coherent's existing product line?
What power supply does the Coherent Osprey laser require?
